Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neurometrix Inc (NURO)

Neurometrix Inc (NURO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,209
  • Shares Outstanding, K 5,629
  • Annual Sales, $ 7,380 K
  • Annual Income, $ -2,090 K
  • 60-Month Beta 3.05
  • Price/Sales 9.25
  • Price/Cash Flow N/A
  • Price/Book 6.94
Trade NURO with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.80 +13.78%
on 08/26/21
19.74 -43.52%
on 08/27/21
-0.16 (-1.41%)
since 08/24/21
3-Month
3.02 +269.21%
on 07/19/21
38.75 -71.23%
on 07/22/21
+7.45 (+201.35%)
since 06/24/21
52-Week
1.47 +658.45%
on 10/29/20
38.75 -71.23%
on 07/22/21
+9.61 (+624.03%)
since 09/24/20

Most Recent Stories

More News
NeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia

NeuroMetrix, Inc. (Nasdaq: NURO) today announced a publication titled "Effects of Wearable Transcutaneous Electrical Nerve Stimulation on Fibromyalgia: A Randomized Controlled Trial" in the Journal of...

NURO : 11.15 (-6.62%)
NeuroMetrix Reports Q2 2021 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis...

NURO : 11.15 (-6.62%)
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell device has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for treating the symptoms of fibromyalgia in...

NURO : 11.15 (-6.62%)
NeuroMetrix, Inc. Announces Date for Second Quarter 2021 Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 second quarter financial results before the opening of the market on July 22, 2021. The Company will host a conference call...

NURO : 11.15 (-6.62%)
NeuroMetrix Reports that Quell(R) Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to determine whether transcutaneous electrical nerve stimulation...

NURO : 11.15 (-6.62%)
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell(R) for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences....

NURO : 11.15 (-6.62%)
NeuroMetrix Reports Q1 2021 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis...

NURO : 11.15 (-6.62%)
NeuroMetrix, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 22, 2021 / NeuroMetrix, Inc. (NASDAQ:NURO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 22, 2021 at 8:00 AM...

NURO : 11.15 (-6.62%)
NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on April 22, 2021. The Company will host a conference call...

NURO : 11.15 (-6.62%)
NeuroMetrix Reports Q4 and Full Year 2020 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company is focused on the development and global commercialization...

NURO : 11.15 (-6.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Key Turning Points

3rd Resistance Point 17.83
2nd Resistance Point 16.64
1st Resistance Point 14.29
Last Price 11.15
1st Support Level 10.75
2nd Support Level 9.56
3rd Support Level 7.21

See More

52-Week High 38.75
Fibonacci 61.8% 24.51
Fibonacci 50% 20.11
Fibonacci 38.2% 15.71
Last Price 11.15
52-Week Low 1.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar